Tech Company Financing Transactions

Marinus Pharmaceuticals Funding Round

Canaan Partners, Domain Associates and Flare Capital Partners joined a $20 million Series B funding round for Marinus Pharmaceuticals. The round was announced by the company on 4/10/2009.

Transaction Overview

Company Name
Marinus Pharmaceuticals
Announced On
4/10/2009
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors

Canaan Partners (Stephen Bloch)

Domain Associates (Nicole Vitullo)

Flare Capital Partners (Andrew Firlik)

Sofinnova Ventures (Anand Mehra)

Proceeds Purpose
The funding will advance the Company's ganaxolone development program for use as a novel adjunctive agent for the treatment of refractory partial seizures and to explore proof of concept studies in psychiatric indications.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
170 N. Radnor Chester Rd. 250
Radnor, PA 19087
USA
Phone
(484) 801-4670
Website
www.marinuspharma.com
Email Address
[email protected]
Overview
Marinus Pharmaceuticals (NASDAQ: MRNS) is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders.
Profile
Marinus Pharmaceuticals LinkedIn Company Profile
Social Media
Marinus Pharmaceuticals Company Twitter Account
Company News
Marinus Pharmaceuticals News
Facebook
Marinus Pharmaceuticals on Facebook
YouTube
Marinus Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Scott Braunstein
  Scott Braunstein LinkedIn Profile  Scott Braunstein Twitter Account  Scott Braunstein News  Scott Braunstein on Facebook
Chief Financial Officer
Edward Smith
  Edward Smith LinkedIn Profile  Edward Smith Twitter Account  Edward Smith News  Edward Smith on Facebook
Chief Medical Officer
Joe Hulihan
  Joe Hulihan LinkedIn Profile  Joe Hulihan Twitter Account  Joe Hulihan News  Joe Hulihan on Facebook
VP - Bus. Development
Thomas Lyons
  Thomas Lyons LinkedIn Profile  Thomas Lyons Twitter Account  Thomas Lyons News  Thomas Lyons on Facebook
VP - Manufacturing
David Czekai
  David Czekai LinkedIn Profile  David Czekai Twitter Account  David Czekai News  David Czekai on Facebook
VP - Regulatory Affairs
Kimberly McCormick
  Kimberly McCormick LinkedIn Profile  Kimberly McCormick Twitter Account  Kimberly McCormick News  Kimberly McCormick on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/10/2009: Celion Networks venture capital transaction
Next: 4/10/2009: AVEO Oncology venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.